Literature DB >> 9726029

Hypotheses on the role of cytokines in peptic ulcer disease.

F S Lehmann1, G A Stalder.   

Abstract

Helicobacter pylori is the cause of chronic type B gastritis and occurs in almost all patients with duodenal ulcers. Infection with H. pylori is characterized by an increased production of several inflammatory cytokines. Increasing evidence suggests a central role of these cytokines in the pathogenesis of H. pylori-associated gastritis and peptic ulcer disease. Cytokines may be crucial in the recruitment and activation of inflammatory cells and in stimulation of gastrin release. In addition to their proinflammatory properties, cytokines may also inhibit the ulcer occurrence by stimulation of prostaglandins and somatostatin release and by direct impairment of acid secretion. The balance of these factors may determine the clinical outcome of H. pylori infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9726029     DOI: 10.1046/j.1365-2362.1998.00306.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  3 in total

1.  Gastric mucosal hyperplasia via upregulation of gastrin induced by persistent activation of gastric innate immunity in major histocompatibility complex class II deficient mice.

Authors:  T Fukui; A Nishio; K Okazaki; N Uza; S Ueno; M Kido; S Inoue; H Kitamura; K Kiriya; S Ohashi; M Asada; H Tamaki; M Matsuura; K Kawasaki; K Suzuki; K Uchida; H Fukui; H Nakase; N Watanabe; T Chiba
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

2.  Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication.

Authors:  A Archimandritis; S Sougioultzis; P G Foukas; M Tzivras; P Davaris; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

3.  Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.

Authors:  Full-Young Chang; Chih-Yen Chen; Ching-Liang Lu; Jiing-Chyuan Luo; Rei-Hwa Lu; Shou-Dong Lee
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.